ClinVar Miner

Submissions for variant NM_000158.4(GBE1):c.568A>G (p.Arg190Gly)

gnomAD frequency: 0.29724  dbSNP: rs2229519
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 18
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Eurofins Ntd Llc (ga) RCV000178721 SCV000230862 benign not specified 2014-06-30 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV000178721 SCV000302749 benign not specified criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000318439 SCV000446313 benign Glycogen storage disease, type IV 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Illumina Laboratory Services, Illumina RCV000375379 SCV000446314 benign Adult polyglucosan body disease 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
GeneDx RCV000178721 SCV000513122 benign not specified 2015-12-02 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Mendelics RCV000318439 SCV001136553 benign Glycogen storage disease, type IV 2019-05-28 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001516921 SCV001725295 benign Glycogen storage disease, type IV; Glycogen storage disease IV, classic hepatic 2024-02-01 criteria provided, single submitter clinical testing
Pars Genome Lab RCV000318439 SCV001738535 benign Glycogen storage disease, type IV 2021-06-15 criteria provided, single submitter clinical testing
Pars Genome Lab RCV000375379 SCV001738536 benign Adult polyglucosan body disease 2021-06-15 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000318439 SCV001933754 benign Glycogen storage disease, type IV 2021-08-10 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000375379 SCV001933755 benign Adult polyglucosan body disease 2021-08-10 criteria provided, single submitter clinical testing
Breakthrough Genomics, Breakthrough Genomics RCV000675509 SCV005299943 benign not provided criteria provided, single submitter not provided
Mayo Clinic Laboratories, Mayo Clinic RCV000675509 SCV000801200 benign not provided 2015-10-20 no assertion criteria provided clinical testing
Natera, Inc. RCV000318439 SCV001461488 benign Glycogen storage disease, type IV 2020-09-16 no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV000178721 SCV001923162 benign not specified no assertion criteria provided clinical testing
Genome Diagnostics Laboratory, University Medical Center Utrecht RCV000178721 SCV001931761 benign not specified no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000178721 SCV001956119 benign not specified no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000178721 SCV001972365 benign not specified no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.